Printable Test Catalog - OU Medicine

REFERENCE RANGE: 0-9 days: 7.6-10.4 mg/dL
10 days-2 years: 9.0-11.0 mg/dL
2-12 years: 8.8-10.8 mg/dL
12-18 years: 8.4-10.2 mg/dL
> 18 years: 8.6-10.0 mg/dL
METHODOLOGY: Indirect Potentiometry
CLINICAL USE: Aid in diagnosis and treatment of parathyroid
disease, a variety of bone diseases, chronic
renal disease and tetany
CPT: 82310
[CA125] CA 125 Antigen
SPECIMEN REQUIRED: Frozen serum
TUBE OR CONTAINER: Gold or Red
SPECIMEN VOLUME: 2 mL
MINIMUM VOLUME: 1 mL
TEST AVAILABILITY: Mon-Wed-Fri
TURNAROUND TIME: 1-3 days
REFERENCE RANGE: 0-21 units/mL
OTHER NAMES: Cancer Antigen (CA) 125
METHODOLOGY: Chemiluminescence
CLINICAL USE: Tumor marker for monitoring disease progression in
nonmucinous epithelial neoplasms of the ovary
CPT: 86304
[CA125FLD] Body Fluid CA 125 Antigen
SPECIMEN REQUIRED: Frozen body fluid
TUBE OR CONTAINER: Sterile tube
SPECIAL HANDLING: Specify source of fluid
SPECIMEN VOLUME: 1 mL
MINIMUM VOLUME: 0.5 mL
TEST AVAILABILITY: Daily
TURNAROUND TIME: 2-3 days
REFERENCE RANGE: None established
OTHER NAMES: Cancer Antigen (CA) 125, Body Fluid
METHODOLOGY: Electrochemiluminescent Immunoassay
CPT: 86304
[CA15] CA 15-3 Antigen
SPECIMEN REQUIRED: Refrigerated serum or plasma
TUBE OR CONTAINER: Red, Gold or Light Green (heparin)
SPECIMEN VOLUME: 2 mL
MINIMUM VOLUME: 0.8 mL
TEST AVAILABILITY: Daily
TURNAROUND TIME: 1-3 days
REFERENCE RANGE: < 0.5-32.4 U/mL
OTHER NAMES: Cancer Antigen (CA) 15-3
METHODOLOGY: Chemiluminescence
CLINICAL USE: Monitor patients with systemic recurrence of
breast carcinoma after diagnosis and initial